申请人:Novo Nordisk Health Care AG
公开号:US20140107324A1
公开(公告)日:2014-04-17
The invention relates to growth hormone compounds with a protracted profile. The effect is obtained by linking an albumin binding residue via a hydrophilic spacer to growth hormone variants. Further described are methods of preparing and using such compounds. These growth hormone compounds are based on there althered profile considered particular useful in therapy.
本发明涉及一种具有持久剖面的生长激素化合物。通过将一种结合白蛋白的残基通过亲水性间隔连接到生长激素变体上,可以获得该效果。还描述了制备和使用这种化合物的方法。这些生长激素化合物基于其改变的剖面,在治疗中被认为特别有用。